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Abstract
Background: Most terminally ill cancer patients prefer to die at home, but a majority die in institutional settings.
Research questions about this discrepancy have not been fully answered. This study applies artificial intelligence
and machine learning techniques to explore the complex network of factors and the cause-effect relationships
affecting the place of death, with the ultimate aim of developing policies favouring home-based end-of-life care.
Methods: A data mining algorithm and a causal probabilistic model for data analysis were developed with
information derived from expert knowledge that was merged with data from 116 deceased cancer patients in
southern Switzerland. This data set was obtained via a retrospective clinical chart review.
Results: Dependencies of disease and treatment-related decisions demonstrate an influence on the place of death of
13%. Anticancer treatment in advanced disease prevents or delays communication about the end of life between
oncologists, patients and families. Unknown preferences for the place of death represent a great barrier to a home
death. A further barrier is the limited availability of family caregivers for terminal home care. The family’s preference for
the last place of care has a high impact on the place of death of 51%, while the influence of the patient’s preference is
low, at 14%. Approximately one-third of family systems can be empowered by health care professionals to provide
home care through open end-of-life communication and good symptom management. Such intervention has an
influence on the place of death of 17%. If families express a convincing preference for home care, the involvement of a
specialist palliative home care service can increase the probability of home deaths by 24%.
Conclusion: Concerning death at home, open communication about death and dying is essential. Furthermore, for
the patient preference for home care to be respected, the family’s decision for the last place of care seems to be key.
The early initiation of family-centred palliative care and the provision of specialist palliative home care for patients who
wish to die at home are suggested.
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Background
Studies report that a majority of cancer patients prefer
to die at home [1–5]. Despite longstanding research con-
cerning the improvement and implementation of policies
favouring end-of-life (EOL) home care, most patients die
in institutional settings. An incongruence of approxi-
mately 20% between patients’ preferred place of death
(POD) and patients’ actual POD has been reported
worldwide [6]. Based on the calculated eight million
deaths from cancer every year, it must be assumed that
approximately 1.6 million cancer patients cannot die at
their preferred location. The trajectory of cancer diseases
is usually characterised by a steady progression and a
short phase of a clear decline prior to death that lasts
weeks or months [7]. These characteristics lead to the
hypothesis that the approaching terminal phase of the
disease might be predictable and that EOL care planning
could be initiated in time to meet the patient’s wishes
and preferences. Assessing preferences for the last place
of care prior to death and for the POD requires challen-
ging conversations among health care professionals, pa-
tients, and family members [8]. In the advanced stages
of the disease, when patients are undergoing anticancer
treatment, these conversations often occur too late to
enable preferences to be turned into reality [9]. This
trend contradicts the hypothesis of the predictability of
death and the ability for advance care planning. It must
be assumed that preferences are often unknown until
the phase of imminent death. The aim of the project is
to identify predictors and favourable patterns for home
death, as well as to examine the possibilities of interven-
tions provided by healthcare professionals to facilitate
home-based EOL. Within this context, the study ex-
plores the question of which variables and dependencies
between variables can be identified with respect to the
POD and what knowledge can be generated for health
care professionals involved in cancer care to better sup-
port the patient’s wish to die at home.
Methods
This study was a retrospective chart review in a regional
cancer centre in the Italian-speaking part of southern
Switzerland. It explored the interplay of a wide spectrum
of factors influencing cancer patients’ POD, such as
disease-, individual-, family-, care network- and policy-
related factors. For this purpose, two research software
tools were developed: a causal probabilistic model for
data analysis and knowledge (a credal network) [10–12]
and a data mining algorithm (a classifier) [13].
Classifiers are one of the main tools used in machine
learning; they are statistical methods that learn from ex-
amples. In our application each example is a pair made
by information about a patient and the related POD (in-
cluding at home, in a hospital or a nursing home). After
being fed with a number of such examples, a classifier
learns by itself the relation between the former and the
latter; whence, after the learning stage, it can be
employed to predict the POD of a patient given the
available information about such a patient. The classifier
used in our study is one of the most well-known and
with a long history of successful applications: the so-
called naive Bayes classifier [14]. We stress that our
classifier was created on the sole basis of empirical data
as reported in Table 1. We measured its predictive
accuracy compared to that of the patient’s care team,
and they turned out to be equivalent.
The second tool that we have employed is a
probabilistic-graphical model called a credal network.
The goal of such a model is more ambitious than that of
a classifier. In fact, the network aims at representing the
phenomenon in its entirety: that is, modelling all the fac-
tors together with their causal interactions, in a joint
way. This enables one to do analysis that a classifier can-
not do, in particular analysis of interventions: for in-
stance, what happens to the POD if one manipulates
some of the factors? If we, for instance, impose the
choice of a certain treatment. This is more demanding,
and arguably more important, than merely doing predic-
tions based on passive observations, since a tool like this
can help to devise new policies without trying them in
reality (something that is not always ethically possible,
or that is costly). Let us note that credal networks are in
close relation with one of the most popular tools in Arti-
ficial Intelligence, which are called Bayesian networks. A
Bayesian network [15] is equivalent to a joint probability
distribution over the factors (variables) of the problem;
it is therefore completely compatible with (Bayesian)
probability theory. A credal network generalises the
concept of Bayesian network to make it more reliable
(robust), while still being completely compatible with
probability theory. It does so by allowing incomplete
knowledge to enter the model. In particular, given the
large spectrum of factors to explore, large amounts of
data would have been required to build the causal prob-
abilistic model using only empirical data from patients.
To compensate for a lack of evidence from the data set,
a further source of information, namely, expert know-
ledge, was exploited. Such a knowledge is organized in a
qualitative and a quantitative part. The former is
provided by means of a directed graph where nodes
represent factors (variables) of the problem and arcs be-
tween them represent cause-effect relations. Quantitative
knowledge is provided in a probabilistic form to express
the strength of the causal relations in the graph. Notably,
credal nets permit such probabilistic knowledge to be
coded in the model without forcing the expert to say,
only for modelling convenience, more than her
knowledge allows: for example, when the expert was
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Table 1 Patient demographic and clinical characteristics and caregiver and care network characteristics
Characteristics Details characteristics Total n = 116
Time interval between assessment and death (days) Mean 38
Range 3–89
Gender Male 52
Female 64
Age(years) 20–40 1
41–65 33
66–80 58
> 80 24
Primary tumour site Gatrointestinal tract 40
Lung 12
Breast 15
All other tumours 48
Time interval between diagnosis and death (days) Mean 922
Range 2–10,465
Place of death Home 21
Hospital 90
Nursing home 5
Time interval between last administration of chemotherapy and death (days) Mean 34
Range 0–247
Distance from residence to cancer centre (km) Mean 4
Range 1–74
Area of residence Rural 31
Urban 85
Living arrangements Alone 40
With spouse 65
With siblings 2
With children 6
Other 3
Visits from palliative physicians Yes 35
No 81
Visits from palliative nurses Yes 93
No 23
Social worker Involved 49
Not involved 67
Volunteers Involved 71
Not involved 45
General practitioner Home visits 39
No home visits 54
Not available 23
Home care services Public home care service 33
Private home care service 41
None provided 42
Continuous home care provided by migrant care workers Provided 3
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uncapable of assessing the precise numerical probability of
a certain event, the model allowed the expert to provide in
its place weaker probabilistic judgments, like that one
event is very probable, or more probable than another,
without requiring a number. This is a necessary basis to
build credible models that deliver reliable inference. The
variables and states of variables used for the causal model
are listed in Table 2 in Additional file 1. Connections be-
tween variables are represented in the directed acyclic
graph presented in Fig. 1 in Additional file 2. A detailed
description of the technical features is given in
Additional file 3. The validation procedure consisted of
retrospectively testing the predictive capacity.
Let us stress finally that both, the classifier and the
credal network, allow one to reason on specific patients:
they are not only a tool for analysis of population. This
is made possible by their underlying probabilistic nature:
whenever one focuses on a new patient, the system (be
it the classifier or the credal net) is fed with information
about that very patient, and the inference engine yields
Table 1 Patient demographic and clinical characteristics and caregiver and care network characteristics (Continued)
Characteristics Details characteristics Total n = 116
Place of care in the 60 days prior to assessment (range 0–60)
Days spent at home Mean 48
Days spent in a hospital Mean 10
Days spent in a nursing home Mean 0
No. of hospitalisations in the 60 days prior to assessment Mean 1
Range 0–3
Karnofsky Performance Status 10–40 41
50–60 63
70–100 12
Symptom burden None-low 6
Medium 36
High 74
Cancer treatment Ongoing 67
Discontinued 49
Patient’s awareness of dying Open 81
Closed 34
Not assessed 1
Patient’s preference for place of death Home 34
Hospital 9
Nursing home 1
Not assessed 72
Family’s awareness of dying Open 87
Closed 18
Not assessed 11
Family system’s conditions for home care Suitable 39
Unsuitable 75
Not assessed 2
Family’s preference for place of death Home 29
Hospital 20
Nursing home 1
Not assessed 66
Care team’s prediction of place of death Home 39
Nursing home 2
Hospital 75
Data obtained by clinical chart review (median 38 days before death)
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prediction for that very patient as a consequence of the
application of Bayes conditioning.
The research tools can be accessed online: http://ipg.
idsia.ch/software.php?id=141.
Data source and setting
Data were gathered in a regional cancer centre from a
total of 116 adult patients who died from cancer be-
tween 2015 and 2016 in southern Switzerland. The three
most frequent cancer diagnoses were of the gastrointes-
tinal tract (34%), breast (13%) and lung (10%). Seventy-
eight percent of the patients died in a hospital, 18% died
at home and 4% died in a nursing home.
Routine data on patients’ demographic and clinical
characteristics were sampled retrospectively through
clinical chart review at a median time of 38 days (range
3–89 days) prior to death. The data set is given in Table
1, and the collection procedure is presented in Table 3
in Additional file 4.
All research procedures were submitted to the
Cantonal Ethics Committee of Ticino. Given the retro-
spective study design, no informed consent from pa-
tients or caregivers could be obtained. Ethical approval
and consent were obtained in September 2016 under the
protocol number Swissethics ID BASEC 2016–01455.
Results
The results mentioned in this section were obtained via
queries with the two research tools, mainly the causal
probabilistic model. Various scenarios of daily clinical
practice were simulated by testing the impact of the vari-
ables and their different states on a target variable. The
output of the model was calculated in the form of prob-
ability intervals with lower and upper values. Therefore,
some of the results are expressed ranges. The remainder
of the results are expressed as percentages, which were
calculated based on differences in the lower values of
the probability interval since a higher prevalence is at-
tributed to variations in the lower value. The results
from these queries are detailed in Table 4 and Table 5 in
Additional file 5.
Results from the causal probabilistic model
Dependencies of disease and treatment-related variables
Among illness-related variables, the following dependen-
cies were observed. As long as effective anticancer treat-
ment resources are available, these resources are most
likely to be used to treat metastatic cancer until near the
EOL, with a 64–80% likelihood of use for this purpose,
with the goal of palliating symptoms and improving
survival. Ongoing cancer treatment prevents or delays
communication about EOL issues between oncologists,
patients and families. Ongoing cancer treatment de-
creases the probability of open communication by 40%
compared with that of treatment discontinuation. In the
investigated study population, the last chemotherapy was
administered at a median of 34 days before death. Of the
patients, 60 to 80% were probably only partially in-
formed about the proximity of death when undergoing
anticancer treatments. Thus, patients and their relatives
are more likely to remain in a closed rather than open
state of awareness of dying. When patients are not aware
of the terminal stage of the disease, they probably do not
communicate about their preferences for the place of
care and POD. Accordingly, assessing preferences for
the EOL period is difficult when patients and families
are not ready to discuss the subject. In the current study,
these preferences were unknown among approximately
two-thirds of the 116 patients at a median of 38 days
prior to death. Eighty-seven percent of these patients
died in a hospital.
Communication between health care professionals, pa-
tients and families about the imminence of death shows
a positive impact on the awareness context of 40%. Most
patients and their relatives (60–80%) shift from a closed
to an open state of awareness of dying following open
communication.
In addition to the influence of ongoing anticancer
treatment on communication and the awareness context,
other aspects must be taken into account. As long as
palliative chemotherapy is continued, the treatment of
toxicities and their consequences require additional sup-
portive care, which leads to higher rates of hospital ad-
missions and consequently to more days spent in a
hospital. The more days patients spend in a hospital, the
more likely they are to die in that setting. The number
of hospital days is also influenced by the symptom
burden. Severe symptoms increase the probability of
prolonged hospital stays. A large proportion of cancer
patients suffer from a high symptom burden or unstable
clinical conditions during the last weeks of life, requiring
inpatient care as long as the treatment approach is
active.
The interplay of these disease and treatment-related
variables shows an influence on the home death rate
of 13%.
Dependencies of patient and family preferences
For patients living at home, preferences for home as the
place of care (37–63%) are slightly higher than prefer-
ences for the hospital (28–53%). Patients resident in a
nursing home prefer to be cared for in that setting (57–
67%), followed by home (23–31%) and then the hospital
(8–14%). Family caregivers’ preferences contrast the
wishes of patients, especially in urban areas and agglom-
erations, where family caregivers clearly prefer hospitals
(48–82%) versus homes (16–49%). In rural areas, there
is almost no difference in preferences for home (35–
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60%) versus the hospital (37–62%). The family’s prefer-
ence shows the highest overall impact on POD at 51%,
which is much higher than the impact of the patient’s
preference, at 14%. The family’s preference is strongly
dominant over the patient’s preferences. A significant
congruence between the family’s preference and POD
can be observed, independent of the patient’s preference:
when the family’s preference is home, the probability of
a home death is high (53–70%); when the family’s
preference is the hospital, the patient is more likely to
die in a hospital (59–87%); and when the family’s
preference is a nursing home, the patient is more likely
to die in a nursing home (50–79). The best probability
for home death is subject to a preference for home care
that is expressed by both patients and family caregivers
(64–76%).
Dependencies of family-related variables
The family’s preference for the last place of care is
mostly influenced by the family system’s conditions for
home care. The probability of suitable conditions is
best (80–100%) when at least one person from the fam-
ily is available to assist with home care, when the family
members have somewhat solid emotional relationships,
when the family members are fully informed about the
patient’s approaching death, when the family members
have an open state of awareness, and when the patient
has a low degree of dependence. Among these variables,
the relevance of the state of awareness seems to be im-
portant. In a state of closed awareness, the suitability of
the family’s conditions for home care drops from 80 to
100 to 60%. An even more obvious trend becomes ap-
parent if no family member is available for home care.
Then, the probability of suitable conditions decreases
from 80 to 100% to 20–40%. An analogous decline from
80 to 100 to 40% is observable in the family’s availabil-
ity for home care when the patient suffers from severe
symptoms, has a high degree of dependence and is in
need of continuous help and support.
Economic resources seem to play a role only for fam-
ilies without their own resources in place for home care
since the families then must pay for expensive assistance
from professional carers. In this event, economic re-
sources show an impact of 20% on the family’s prefer-
ence. These circumstances might be country specific. In
the current study population, continuous assistance
provided by health professionals or care workers with
migrant backgrounds is not provided for by law and is
therefore not covered by health insurance. Only three of
the 116 families in the study had chosen this solution.
The interplay of all family-related variables, excluding
the family’s preference, demonstrates a final impact on
POD of 13%. However, a clear prediction for home
death cannot be made as long as the family’s preference
is unknown.
Dependencies of care network and policy-related variables
To support the design of policies, the impacts of the fol-
lowing potentially modifiable variables were tested. The
use of specialist palliative home care services, access to
home visits by GPs, access to home care nurses, access
to volunteer hospice services and coverage of home care
costs by health insurance reflect the effect of an interdis-
ciplinary home care network and health care policy. The
interplay of this group of modifiable variables demon-
strates an impact on the home death rate of only 6%
when patient and family preferences are unknown. In
contrast, in the subgroup of patients and families with a
congruent preference for home care, an interdisciplinary
home care network can consistently increase the prob-
ability of home death by at least 58%. These patients ac-
tually have the highest probability of dying at home
overall, at 76–83%. Without the use of specialist pallia-
tive home care services, the chance of dying at home
decreases by 24%, but the likelihood of a home death is
still higher than that of a hospital death, at 51–59% ver-
sus 41–50%, respectively. No difference is observed in
the impact on the likelihood of a home death between
routine and continuous professional home care. Con-
tinuous professional assistance does not seem to be
more effective than routine home care.
As shown before, if the family’s preference for the
POD is the hospital, despite full access to an interdiscip-
linary home care network, the probability of dying at
home drops significantly by 57%, from 76 to 83% to 19–
40%. This finding confirms the strong impact of the
family’s preference on POD and leads to the hypothesis
that if interventions by the interdisciplinary home care
network could influence the family’s choice for the place
of care, the home death rate would increase significantly.
However, these variables reveal a low impact on the
family’s preference of only 4%. As a result, the family
decision-making process depends neither on the home
care network nor on the health care policy but rather
mainly on the family conditions for home care.
In the search for hypothetical interventions to better
support family conditions, open EOL communication
that improves the state of awareness and good symptom
control can be identified as an option. The impact of
such an intervention demonstrates an increased prob-
ability of suitable conditions for home care by 35%,
yielding a final influence on the home death rate of 17%.
Results from the classifier
The results from the classifier mainly confirm the results
obtained from the causal model. A high probability of
home death (97%) is observed for patients who live in a
Kern et al. BMC Palliative Care          (2020) 19:160 Page 6 of 10
rural environment, have a low symptom burden, have
spent few days in a hospital, have an open awareness of
dying, have a suitable family system for home care, have
congruent preferences for home care with their families,
receive home care assistance provided by a home care
service, have access to GP home visits and have access
to specialist palliative home care. In urban areas, the
probability of death at home drops slightly to 82%.
Without the involvement of a specialist palliative home
care service, the probability decreases significantly to
46%. When severe symptoms set in, even though all
other conditions appear favourable, the probability of
home death drops from 82 to 59%. In the case of a long
hospital stay, the chance of death at home is only 23%.
This tendency becomes even more apparent when the
family’s awareness of dying is closed. Then, the probabil-
ity of home death decreases to just 13%.
Discussion
The aim of this project was to explore predictors and
favourable patterns for home death. The main results of
this study largely explain the reality of the low percent-
age of home deaths among cancer patients. With respect
to the POD, two main processes can be defined as rele-
vant. The family preference for place of care, with an
influence of 51%, and dependencies on disease and
treatment-related decisions, with an influence of 13%,
represent the key factors.
The cause-effect relationships between the investigated
variables seem to be initiated by the increasing availabil-
ity of effective anticancer treatment resources. An active
treatment attitude close to the dying phase delays com-
munication about approaching death and therefore de-
creases the probability of conversations about EOL
preferences. Several authors have reported findings that
support these assertions. Difficulties in determining the
adequate timing of the disclosure of imminent death
[16], high burdens on oncologists when communicating
treatment discontinuation [17, 18], inaccurate prediction
of the survival time [19], a goal to not deprive patients
of hope [18], and unrealistic expectations and requests
of patients and families [20, 21] represent relevant bar-
riers to effective EOL communication. The relationship
between the timing of communication about death and
the POD must be considered significant. If EOL conver-
sations occur late, the time of the conversation will be
too late to assess patient and family preferences and to
prepare the family for the challenging task of home care.
EOL caregiving is complex and frightening. As reported
by Thomas, fear about not having experience and cap-
acity to take care of a terminally ill person, a lack of un-
derstanding of symptom progression and management,
as well as uncertainty about what might happen when
death is imminent and how to deal with imminent death
are known burdens in family caregivers [22]. Family
members spend an average of 43 h a week providing
care. When continuous assistance is necessary, spouses
may provide up to 100 h per week [23]. The availability
of caregiving at home drops significantly when symp-
toms set in and patients become completely dependent
on physical care. However, the nature of most advanced
cancer diseases causes severe symptoms or rapidly chan-
ging clinical conditions, which does not support a peace-
ful EOL period at home. Taking care of a dying relative
at home can be an unstable transition, during which
families struggle for normality and are challenged by
changing roles and relationships and ambivalent feelings
[24]. Thus, the family has to be seen as a social system
in which resources might be aligned not only to the
preferences of the dying family member but also to the
attempt to maintain a normal life that includes jobs,
childcare and other activities of a busy daily life. Key
family caregiver characteristics that increase the likeli-
hood of a home death are female gender and a high level
of ability to deliver care at home for as long as necessary
[25]. Furthermore, awareness about the imminent dying
process is of central importance. When families lack an
understanding of death, the conditions for home care re-
main more likely not to be suitable. Death needs to be
discerned and accepted, and at least one family caregiver
should assume the responsibility of allowing death to
occur at home [26]. Therefore, the results of this study
highlighting the strong influence of family-related vari-
ables on POD are not surprising. Ultimately, it is the
family system that decides on the place of care for the
dying member. The family’s choice for the place of care
cannot be influenced by healthcare professionals; it
mostly depends on personal resources, experiences,
coping strategies and caring attitudes. Patients without
family support have almost no chance for home care un-
less they have high economic resources for external care.
Preferences for the place of care
Patient preferences for home as the place of care, at 37–
63%, were surprisingly lower than expected in compari-
son with preferences for the hospital, at 28–53%, which
were higher than assumed. However, these results con-
firm the tendency of a broadly acknowledged higher
preference for a home death [3–6]. A systematic review
of the United Kingdom literature highlighted a contrast-
ing view of patient preferences, concluding that patients’
preferred POD is unknown because of large amounts of
missing data and the handling of these missing data. Pa-
tients might not express their wishes regarding their
POD depending on the person asking the question, the
setting and the context [27]. Rainsford confirmed that
wishes and preferences might not be the same. A major
concern of terminally ill people is not to be a burden on
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their relatives, and therefore, they might express a pref-
erence for hospital care [1]. According to Pleschberger,
“what is said is often not what is meant”, and perspec-
tives can change over time [28]. A quarter of the patients
with a preference for home death changed their opinions
when death was imminent [6]. The patient’s wish to die
at home can be based on two different meanings of
home: home as a concrete living place or home as a
metaphor for well-being within a benevolent environ-
ment [29]. For people living alone without any family
support, the preference for home might lose its meaning
because what dying patients basically need is someone
to take care of them.
The nursing home seems to be a preference only for
those patients who lived in a nursing home before the ter-
minal stage of their illness (57–68%). For these patients,
the nursing home has become their second home. As a
second choice, they would prefer to be cared for at home,
but this option is unlikely to be realistic because residents
of nursing homes probably do not have a supportive fam-
ily network available to take care of them at home. Prefer-
ences for the hospital can be considered low in residents
of nursing homes, at 8–14%. For patients living at home,
the nursing home is the least preferred place of care, at 6–
14%. In the literature, data regarding the preference for a
nursing home are less available than data for home and
hospital preferences. The reported range of 1–12% is
slightly lower than that found in the current study, but it
confirms this tendency [6].
The family caregiver preferences contrast the wishes of
patients, especially in urban areas and agglomerations,
where the preference is clearly for hospitals, 48–81%,
versus homes 16–49%. In rural areas, no difference be-
tween home and hospital can be observed. This might
be explained by cultural or traditional attitudes in care-
giving. A systematic review based on the results of 210
studies confirmed higher preferences for home among
patients than among family caregivers [5]. The highest
probability of a home death was found for patients and
families with an agreed preference for home care, at 64–
76%. A high congruence between the family caregiver
preference and the actual POD [30], a poor congruence
between patient and family preferences and the domin-
ance of the family preference over the patient preference
have been reported in other studies [31]. It can be con-
cluded that the question of where cancer patients prefer
to be cared for at the end of their lives and where they
would prefer to die cannot be fully answered, but prefer-
ences for home seem to be prevalent, while family care-
givers more often prefer hospital EOL care.
Care network and health care policy
Access to an interdisciplinary home care network in-
cluding specialist palliative home care services increases
the number of deaths at home, but not significantly, with
an increase of only 6%, in a general population of cancer
patients when preferences are unknown. By contrast, an
increased probability of 58% can be observed when both
the patient’s and family’s preferences are for home and
when they are assisted by an interdisciplinary home care
network. These findings are identical to those of Costa
et al., Costa and Alonso-Babarro et al. [2, 32, 33]. Spe-
cific home care programmes that include visits from
GPs and home care nurses in addition to specialist pal-
liative home care services are essential support for pa-
tients and families who prefer home as the place of care.
For this constellation of conditions, the model expresses
the highest probability of a home death of 76–83%. The
question about home care frequency cannot yet be fully
answered since it is unknown whether continuous care
is effective in increasing the home death rate [34]. In the
current study, no difference between routine and con-
tinuous professional home care was observed. Continu-
ous home care seems to not be more effective than
routine home care. This might be explained by a poor
acceptance of external carers in this study population.
Only three of 116 patients had continuous care provided
by care workers with migrant backgrounds. The benefit
of home care likely occurs when the care is provided by
family members rather than professional carers. A care
programme similar to the hospital, with nurses or other
health care professionals continuously present at the
home, is not what patients and families want. As Grone-
meyer and Heller stated, the concept of home is lost
when the hospital is outsourced to the home [35].
Regarding the family’s decision-making process for
the place of care, a multidisciplinary home care team
seems to have almost no influence, at 4%. The family’s
choice depends mostly on their own resources and
coping strategies. Open communication is a more
relevant factor, as it improves the state of awareness of
patients and families. Open communication and good
symptom control can enhance the family system’s con-
ditions for home care by 35%, demonstrating a final
impact on POD of 17%. This percentage can be consid-
ered important in the context of an incongruence of
approximately 20% between the preferred and actual
POD.
Limitations
To the best of our knowledge, this is the first attempt to
comprehensively depict the complexity and causality of
the POD topic through the application of state-of-the-
art artificial intelligence techniques, such as classifiers
and credal networks. Despite the high congruence of the
reported results with those of evidence-based publica-
tions, our models have obviously also some limitations.
The classifier has been inferred on the basis of a small
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data set. Even though its accuracy has proven competi-
tive with that of human experts, one should not blindly
trust its predictions that could, for instance, be more
uncertain on some patients than on some others. We
recommend collecting more data for future develop-
ments of such a predictive tool. With regard to the
credal network, its main weakness, which is also part of
its strength, is that it relies for a large part on expert
knowledge. We have tried to minimize possible subject-
ive biases by checking the literature with care for broadly
shared knowledge about the POD problem. But of
course, some bias can still be present.
The data set collected in only one cancer centre repre-
sents a further limitation, as cultural and regional effects
could affect some results.
Conclusions
Although these limitations need to be considered, we
think that the main results can be of interest to health
care providers in a global context, as the study reveals
two crucial issues for confronting incurable cancer: diffi-
culties in communicating about death and dying and the
limited availability of EOL home care by family care-
givers. The temporal domain appears to be one of the
most relevant factors. The late timing of EOL conversa-
tions due to available treatment options delays the as-
sessment of the patient’s wishes and needs. Struggling
against the disease and maintaining hope seem to be fre-
quent coping strategies. The wish to continue anticancer
treatment might outweigh the desire to spend the last
weeks of life at home and to die there. The question of
where patients prefer to die needs to be viewed in the
whole context of the circumstances characterising the
last few weeks or days of life, in which some aspects
might be more relevant than others. The family system
plays the most important role in this context. The
family’s preference shows the overall strongest impact
on the POD. Therefore, to support the patient’s prefer-
ence for a home death, interventions need to be directed
at the family system. Home care of dying patients needs
to start in a timely fashion. Early initiation of home care
requires a considerable effort initiated by the oncologist
as the principal communicator about treatment deci-
sions, as well as optimal collaboration within the inter-
disciplinary care network and the family. Approximately
one-third of family systems can be empowered by open
EOL communication and good symptom control when
favourable conditions are recognised at the right time.
Considering that these factors might influence decision
making among family systems by as much as 35%, pro-
viding specialist palliative home care that offers family-
centred palliative care would be the ideal solution for all
families with favourable preconditions for home care.
The involvement of a specialist palliative home care
team can be suggested for patients and families who ex-
press a strong preference for EOL home care.
The developed research tools can be used as a basis
for the implementation of sensitivity concepts in cancer
networks. The classifier performed best in prediction
and might be used as an assessment tool in clinical prac-
tice. The credal net model is easily understandable to
non-specialists of these methodologies, thanks to its
graphical representation; for this reason, such a model
could be employed as an educational tool for health care
professionals to gain a deeper understanding of the caus-
ality and complexity of the topic of dying at home. More
generally speaking, we hope that our effort to code the
overall interactions between factors in the POD problem
can serve as a basis for discussion, criticism, and eventu-
ally improvements of this model.
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